Product Name: DSS1 antibody [N1C3]
Applications: WB-Ag
Predicted Target Size: 8 kDa (note)
Positive Controls: Target recombinant protein
Form Supplied: Liquid
Concentration: 0.63 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: split hand/foot malformation (ectrodactyly) type 1
Background: The product of this gene has been localized within the split hand/split foot malformation locus SHFM1 at chromosome 7. It has been proposed to be a candidate gene for the autosomal dominant form of the heterogeneous limb developmental disorder split hand/split foot malformation type 1. In addition, it has been shown to directly interact with BRCA2. It also may play a role in the completion of the cell cycle. [provided by RefSeq]
Synonyms: DSS1 antibody, ECD antibody, SEM1 antibody, SHFD1 antibody, SHSF1 antibody, Shfdg1 antibody, SHFM1 antibody, deleted in split-hand/split-foot 1 antibody, deleted in split hand/split foot protein 1 antibody, split hand/foot malformation type 1 protein antibody, split hand/foot deleted protein 1 antibody, 26S proteasome complex subunit DSS1 antibody, split hand/foot malformation (ectrodactyly) type 1 antibody
Cellular Localization:
CAS NO: 286930-03-8
Product: Etifoxine
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human DSS1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity:
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26984393?dopt=Abstract
